Selenium Fumarate

Selenium fumarate is a synthetic selenium salt formed by bonding selenium with fumaric acid, theoretically intended as a bioavailable selenium delivery form. No peer-reviewed research, clinical trials, or documented biological activity exists for this specific compound in human or animal models.

Origin & History

Selenium Fumarate is not a recognized compound in standard chemical databases, with no documentation in PubChem, DrugBank, or toxicological profiles. While elemental selenium exists as a trace mineral naturally occurring in soil and plants, no specific information exists on fumarate salts or forms of selenium, suggesting this may be a non-standard, hypothetical, or misnamed form not covered in scientific literature.

Historical & Cultural Context

No historical or traditional medicine context exists for Selenium Fumarate. The compound has no references in traditional use databases or historical texts, as it appears to be a non-standard form not documented in any cultural or medicinal traditions.

Health Benefits

• No documented health benefits - no clinical trials or studies exist for Selenium Fumarate
• No evidence of therapeutic effects - compound not recognized in medical literature
• No established biological activity - no biochemical pathway data available
• No traditional or modern use documented - absent from all standard databases
• No safety or efficacy data - compound appears to be non-existent in scientific records

How It Works

No established mechanism of action has been documented for selenium fumarate specifically. Theoretically, if selenium were liberated from the fumarate salt after ingestion, free selenium ions could potentially be incorporated into selenoproteins such as glutathione peroxidase (GPx) and thioredoxin reductase (TrxR), which are central to antioxidant defense and redox signaling. However, no pharmacokinetic, bioavailability, or enzymatic data exist to confirm selenium is meaningfully released or utilized from this particular salt form.

Scientific Research

No human clinical trials, RCTs, or meta-analyses exist for Selenium Fumarate. The research dossier found zero matches in PubMed or other scientific databases, with no PMIDs available as this compound is not documented in any peer-reviewed literature.

Clinical Summary

As of the current date, zero clinical trials, observational studies, in vitro studies, or animal studies have been published specifically examining selenium fumarate. The compound does not appear in PubMed, EMBASE, or major pharmacological databases as a studied entity. By contrast, other selenium forms such as selenomethionine, sodium selenite, and selenium-enriched yeast have extensive human trial data supporting their bioavailability and health effects. The complete absence of evidence means no efficacy, dosing, or safety conclusions can be drawn for selenium fumarate specifically.

Nutritional Profile

Selenium Fumarate is not a recognized or well-characterized compound in standard pharmaceutical, nutritional, or chemical databases. Unlike established selenium supplements such as Sodium Selenite (Na2SeO3), Selenomethionine (C5H11NO2Se), or Selenium Yeast, 'Selenium Fumarate' does not appear in authoritative references (e.g., USP, EFSA, WHO monographs). A hypothetical compound formed between selenium and fumaric acid (C4H4O4) could theoretically provide elemental selenium (atomic weight 78.96 g/mol), but no standardized formulation, elemental selenium concentration, or stoichiometric data exists. For comparison, recognized selenium forms typically deliver 50–200 µg of elemental Se per dose, with bioavailability ranging from ~50% (sodium selenite, inorganic) to ~90% (selenomethionine, organic). No data on fumarate-bound selenium bioavailability, absorption kinetics, or tissue distribution is available. The fumarate moiety (as seen in legitimate supplements like ferrous fumarate, where fumaric acid serves as a counterion to improve solubility and absorption of iron) could theoretically enhance mineral absorption, but this has never been studied or validated for selenium. No macronutrient content (protein, fat, carbohydrate, fiber) is applicable as this would be a trace mineral supplement. No bioactive compound profile, vitamin content, or micronutrient co-factors have been documented. The compound lacks a CAS registry number specific to 'selenium fumarate,' has no established Certificate of Analysis parameters, and no Good Manufacturing Practice (GMP) specifications exist. Given the complete absence of analytical, pharmacokinetic, and nutritional data, no reliable nutritional profile can be constructed. Consumers and practitioners should rely on well-established selenium forms — Selenomethionine (best bioavailability, ~90%), Selenium-enriched yeast (organic matrix, ~60–80% bioavailability), Sodium selenite (inorganic, ~50% bioavailability), or Methylselenocysteine — all of which have robust safety, efficacy, and compositional data.

Preparation & Dosage

No clinically studied dosages exist for Selenium Fumarate as it is not a recognized compound. No forms (extract, powder, standardized) or standardization details are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined - compound not recognized

Safety & Interactions

No safety profile, toxicology data, or drug interaction studies exist for selenium fumarate as an isolated compound. General selenium toxicity risks apply by extrapolation: excess selenium intake above 400 mcg per day in adults can cause selenosis, characterized by hair loss, nail brittleness, gastrointestinal distress, and neurological symptoms. Selenium compounds broadly may interact with anticoagulants, chemotherapy agents, and statins, though these interactions are not confirmed for selenium fumarate. Pregnant or breastfeeding individuals should avoid unresearched selenium salts, as selenium is teratogenic at high doses and the fumarate form carries no established safe dosage.